Generation of an induced pluripotent stem cell line (HMSCATi004-A) from an early onset Parkinson's disease patient with PRKN gene mutation

被引:0
|
作者
Cheng, Jingke [1 ,2 ]
Zhai, Yingtong [1 ,2 ]
Guo, Xiangge [1 ,2 ]
Wang, Xumeng [1 ,2 ]
Ma, Min [1 ,6 ]
Ren, Xin [5 ]
Wang, Shan [5 ]
Cui, Huixian [1 ,2 ,3 ]
Ren, Qian [1 ,2 ,3 ,4 ]
机构
[1] Hebei Med Univ, Dept Human Anat, Shijiazhuang, Peoples R China
[2] Hebei Med Univ, Int Cooperat Lab Stem Cell Res, Shijiazhuang, Peoples R China
[3] Hebei Med Univ, Hebei Key Lab Neurodegenerat Dis Mech, Shijiazhuang, Peoples R China
[4] Minist Educ, Key Lab Neural & Vasc Biol, Shijiazhuang, Peoples R China
[5] Hebei Med Univ, Dept Neurol, Hosp 2, Shijiazhuang, Peoples R China
[6] Hebei Med Univ, Human Brain Bank, Shijiazhuang, Peoples R China
关键词
D O I
10.1016/j.scr.2024.103578
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Parkin (PRKN) is recognized as causative gene in early-onset Parkinson's disease (PD). Induced pluripotent stem cells (iPSCs) were derived from a 29-year-old PD patient carrying a heterozygous c.823C > T (p.R275W) variant and an exon 2-4 deletion in PRKN. The Generated iPSCs maintain a normal karyotype, express pluripotency markers, and retain the ability to differentiate into the three germ layers. This iPSC line serves as a valuable cellular model for investigating the pathogenesis of early-onset PD and development of potential therapeutic interventions.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Generation of induced pluripotent stem cell line (XWHNi002-A) from a female with APP gene mutation
    Sun, Wenxian
    Wang, Pin
    Gong, Jin
    Chen, Yufei
    Yang, Yuting
    Luan, Heya
    Li, Shaoqi
    Li, Ruina
    Wei, Cuibai
    STEM CELL RESEARCH, 2023, 71
  • [32] Generation of an induced pluripotent stem cell line (GIBHi004-A) from a Parkinson's disease patient with mutant DJ-1/PARK7 (p.L10P)
    Li, Yunpan
    Ibanez, David P.
    Fan, Wenxia
    Zhao, Ping
    Chen, Shuhan
    Abdul, Mazid Md
    Jiang, Yu
    Fu, Lixin
    Luo, Zhiwei
    Liu, Zhenhua
    Yang, Yueli
    Guo, Jifeng
    Volpe, Giacomo
    Kanwal, Shahzina
    Wang, Dongye
    Tang, Beisha
    Li, Wenjuan
    STEM CELL RESEARCH, 2020, 46
  • [33] A generation of human-induced pluripotent stem cell line (MUi032-A) from a Choroideremia disease patient carrying a hemizygous mutation on the CHM gene
    Pongpaksupasin, Phitchapa
    Wongkummool, Wasinee
    Tong-Ngam, Pirut
    Jearawiriyapaisarn, Natee
    Paiboonsukwong, Kittiphong
    Sangkitporn, Siripakorn
    Trinavarat, Adisak
    Atchaneeyasakul, La-Ongsri
    Tubsuwan, Alisa
    STEM CELL RESEARCH, 2022, 65
  • [34] Generation of an induced pluripotent stem cell line (SMBCi022-A) from a patient with Fabry disease
    Li, Zihan
    Luan, Jing
    Yang, Yali
    Li, Guowei
    Hu, Zhouhui
    Yu, Che
    Cui, Yazhou
    Han, Jinxiang
    STEM CELL RESEARCH, 2025, 83
  • [35] Generation of a human induced pluripotent stem cell line, BRCi004-A, derived from a patient with age -related macular degeneration
    Kamata, Kazuma
    Otsuka, Yuki
    Imamura, Keiko
    Oishi, Akio
    Kondo, Takayuki
    Suga, Mika
    Shibukawa, Ran
    Okanishi, Yasue
    Sagara, Yukako
    Tsukita, Kayko
    Yasukawa, Tsutomu
    Usui, Hideaki
    Muguruma, Keiko
    Tsujikawa, Akitaka
    Inoue, Haruhisa
    STEM CELL RESEARCH, 2020, 45
  • [36] Generation of induced pluripotent stem cell line (ZZUi004-A) from urine sample of a patient with spinocerebellar ataxia type 3
    Wang, Yanlin
    Shi, Changhe
    Wang, Zhilei
    Sun, Huifang
    Yang, Zhihua
    Zhang, Fan
    Liu, Yutao
    Liu, Han
    Jiang, Chenyang
    Zhang, Shoutao
    Xu, Yuming
    Wen, Xuejun
    STEM CELL RESEARCH, 2018, 28 : 71 - 74
  • [37] Generation of an induced pluripotent stem cell line (CSC-32) from a patient with Parkinson's disease carrying a heterozygous variation p.A53T in the SNCA gene
    Azevedo, Carla
    Chumarina, Margarita
    Serafimova, Evgenija
    Goldwurm, Stefano
    Collin, Anna
    Roybon, Laurent
    Savchenko, Ekaterina
    Pomeshchik, Yuriy
    STEM CELL RESEARCH, 2020, 43
  • [38] Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7
    Chen, Zhi-Ting
    Zhao, Zhen-Hua
    Chen, Li-Na
    Fan, Fei
    Cai, Guo-En
    Weng, Hui-Dan
    Wang, Ying-Qing
    Liao, Lian-Ming
    Chen, Xiao-Chun
    Huang, En
    Ye, Qin-Yong
    STEM CELL RESEARCH, 2021, 51
  • [39] Generation of a human induced pluripotent stem cell line (CSC-40) from a Parkinson's disease patient with a PINK1 p.Q456X mutation
    Russ, Kaspar
    Marote, Ana
    Savchenko, Ekaterina
    Collin, Anna
    Goldwurm, Stefano
    Pomeshchik, Yuriy
    Roybon, Laurent
    STEM CELL RESEARCH, 2018, 27 : 61 - 64
  • [40] Generation of an induced pluripotent stem cell line (EURACi005-A) from a Parkinson's disease patient carrying a homozygous exon 3 deletion in the PRKNgene
    Zanon, Alessandra
    Riekschnitz, Diana
    von Troyer, Michael
    Volpato, Claudia
    Picard, Anne
    Cantaloni, Chiara
    Di Segni, Marina
    Silipigni, Rosamaria
    Pramstaller, Peter P.
    Hicks, Andrew A.
    Pichler, Irene
    STEM CELL RESEARCH, 2019, 41